| NCT ID | NCT03043313 |
| Title | Tucatinib (ONT-380) and Trastuzumab for Patients With HER2-positive Metastatic Colorectal Cancer (MOUNTAINEER)Tucatinib (ONT-380) and Trastuzumab for Patients With HER2-positive Metastatic Colorectal Cancer (MOUNTAINEER) (MOUNTAINEER) |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | yes |
| Sponsors | Academic and Community Cancer Research United |
| Indications | |
| Therapies | |
| Age Groups: | adult senior |